Fátima Damas-Hermoso

Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s disease

E. Tolosa, J. Suárez, F. Rodríguez de Fonseca, 2022, Clinical parkinsonism & related disorders.

May serum levels of advanced oxidized protein products serve as a prognostic marker of disease duration in patients with idiopathic Parkinson's disease?

J. Chacón, J. García-Moreno, M. García‐Sánchez, 2013, Antioxidants & redox signaling.

Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease

E. Tolosa, J. Suárez, F. Rodríguez de Fonseca, 2021, Antioxidants.